Related references
Note: Only part of the references are listed.A Decision Model of Therapy for Potentially Resectable Pancreatic Cancer
Jacob P. VanHouten et al.
JOURNAL OF SURGICAL RESEARCH (2012)
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
Stefan Heinrich et al.
BMC CANCER (2011)
Neoadjuvant Therapy Is Associated With Improved Survival in Resectable Pancreatic Adenocarcinoma
Avo Artinyan et al.
CANCER (2011)
Out-of-Pocket Costs for Accessing Adjuvant Radiotherapy Among Canadian Women With Breast Cancer
Sophie Lauzier et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
Klaus Sahora et al.
SURGERY (2011)
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
Do-Youn Oh et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Current Status of Adjuvant Therapy for Pancreatic Cancer
Matthew H. G. Katz et al.
ONCOLOGIST (2010)
Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing?
Michele Reni
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database
May Piperdi et al.
HPB (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
R. Le Scodan et al.
ANNALS OF ONCOLOGY (2009)
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
H. Ueno et al.
BRITISH JOURNAL OF CANCER (2009)
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
Chigusa Morizane et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Phase II trial of S-1 in combination with gemcitabine for chemo-na⟨ve patients with locally advanced or metastatic pancreatic cancer
Gyeong-Won Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
Yousuke Nakai et al.
ONCOLOGY (2009)
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
Ruchika Gutt et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Prospective phase II trial of Neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head
Stefan Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A late phase II study of S-1 for metastatic pancreatic cancer
Takuji Okusaka et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Delayed gastric emptying (DGE) after pancreatic surgery:: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Moritz N. Wente et al.
SURGERY (2007)
Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation - Long-term results of EORTC trial 40891
Hans G. Smeenk et al.
ANNALS OF SURGERY (2007)
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
Chandrajit P. Raut et al.
ANNALS OF SURGERY (2007)
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin
Daniel H. Palmer et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer - Long-term results
Satoshi Hirano et al.
ANNALS OF SURGERY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Postoperative pancreatic fistula: An international study group (ISGPF) definition
C Bassi et al.
SURGERY (2005)
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer
H Ueno et al.
ONCOLOGY (2005)
Pancreatic Cancer Registry in Japan - 20 years of experience
S Matsuno et al.
PANCREAS (2004)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
